Search
for
Sort by
Research 61–90 of 1000+
- 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Hypersensitivity Diseases
- Cutaneous manifestations of endocrine diseases in children
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Extracellular vesicles derived from embryonic day 13 fetal mouse dermal fibroblasts exhibit potential antifibrotic activity
- Cardiovascular risk in patients with selected cutaneous diseases
- The Human Skin Microbiome in Selected Cutaneous Diseases
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Hair, Cutaneous Homeostasis and Stem Cell Functions
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Clinical and Trichoscopic Patterns of Hair Loss in Systemic Lupus Erythematosus and its Correlation with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- 565 Cutaneous delivery of LEKTI via an engineered strain of staphylococcus epidermidis for the treatment of netherton syndrome
- Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan
- A Neglected case of Systemic lupus erythematosus presenting by Degos’ skin disease and diffuse non-scarring alopecia with dramatic response to treatment, clinically and dermoscopy.
- Thyroid hormone action on skin.
- The Demonstration of Cutaneous Nerves*
- Granzyme B in Autoimmune Skin Disease
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Alopecia areata update
- Cardiovascular Disease-Associated Skin Conditions
- Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- INTERFERONS IN DERMATOLOGY
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity